Á lódáil...
Prevalence of CD8(+) cytotoxic lymphocytes in human neoplasms
PURPOSE: Immune checkpoint inhibitors have recently been approved by the US FDA as first and/or second line therapy in a subset of cancer types. Recent evidence suggests that the quantity of tumor infiltrating lymphocytes (TILs) influences the likelihood of response to immune checkpoint inhibitors....
Na minha lista:
| Foilsithe in: | Cell Oncol (Dordr) |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Springer Netherlands
2020
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7214387/ https://ncbi.nlm.nih.gov/pubmed/32141029 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13402-020-00496-7 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|